hematologic cancer (Cancer)
Information
- Disease name
- hematologic cancer
- Disease ID
- DOID:2531
- Description
- "An organ system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes." [url:http\://en.wikipedia.org/wiki/Blood_cancer, url:http\://www.cancer.gov/dictionary/?CdrID=45708]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04035447 | Active, not recruiting | N/A | Symptom Management for YA Cancer Survivors | January 22, 2020 | May 30, 2024 |
| NCT05690230 | Active, not recruiting | N/A | Improving Patient Experience: BMBA | December 5, 2022 | April 28, 2024 |
| NCT05493800 | Active, not recruiting | Phase 2 | Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT | February 1, 2022 | December 30, 2024 |
| NCT00742560 | Completed | Phase 2 | A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma | August 2008 | October 2016 |
| NCT04235153 | Completed | CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients | January 9, 2020 | March 12, 2020 | |
| NCT04966156 | Completed | N/A | Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT | September 8, 2021 | January 31, 2023 |
| NCT05465577 | Completed | N/A | Coverage and Cost-of-Care (CC) Links- Financial Navigation Program | April 1, 2021 | February 1, 2022 |
| NCT06053918 | Completed | Research-Action in Hematology From Hospitalization to Home | May 7, 2019 | March 31, 2021 | |
| NCT06260111 | Not yet recruiting | N/A | Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation | April 10, 2024 | October 30, 2025 |
| NCT06279585 | Not yet recruiting | N/A | Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD | March 1, 2024 | September 2025 |
| NCT06377059 | Not yet recruiting | N/A | Early Detection of Complications During Immunotherapy for Haematological Malignancy | July 1, 2024 | July 1, 2027 |
| NCT05602168 | Not yet recruiting | N/A | Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance | January 2023 | January 2030 |
| NCT05481502 | Recruiting | N/A | An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors | June 8, 2022 | July 1, 2026 |
| NCT05626764 | Recruiting | QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management | January 27, 2020 | December 2024 | |
| NCT05142033 | Recruiting | Avera Cancer Sequencing and Analytics Protocol (ASAP) | November 1, 2021 | December 31, 2026 | |
| NCT05323409 | Recruiting | N/A | Improving Comprehensive Care of Cancer Patients | April 1, 2022 | June 2025 |
| NCT05375643 | Recruiting | N/A | SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | April 3, 2023 | July 30, 2025 |
| NCT05715047 | Recruiting | N/A | Intervention for Fatigue in HCT Recipients | November 28, 2023 | September 1, 2026 |
| NCT05753501 | Recruiting | Phase 1 | Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies | June 9, 2023 | April 11, 2029 |
| NCT05866757 | Recruiting | N/A | Discontinuation Study | August 28, 2023 | August 2025 |
| NCT05942885 | Recruiting | N/A | Hypnosis: a Path to Appeasement | October 30, 2023 | July 30, 2025 |
| NCT03955276 | Terminated | An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme) | February 7, 2019 | January 13, 2021 | |
| NCT04412135 | Unknown status | The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality | June 2020 | June 2021 | |
| NCT04822974 | Unknown status | N/A | TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS | May 1, 2021 | September 1, 2022 |
| NCT05175508 | Unknown status | Phase 2/Phase 3 | Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS | May 1, 2021 | May 1, 2023 |
| NCT03091933 | Unknown status | Phase 1/Phase 2 | Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) | February 6, 2017 | March 31, 2019 |
| NCT01792882 | Withdrawn | Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples | February 2013 | February 27, 2023 | |
| NCT05061654 | Withdrawn | Phase 4 | CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients | August 2022 | June 2024 |
- Disase is a (Disease Ontology)
- DOID:0050686
- Cross Reference ID (Disease Ontology)
- MESH:D019337
- Cross Reference ID (Disease Ontology)
- NCI:C27134
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:414388001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0376544
- Exact Synonym (Disease Ontology)
- blood cancer
- Exact Synonym (Disease Ontology)
- Hematologic malignancy
- Exact Synonym (Disease Ontology)
- Hematologic neoplasm
- Exact Synonym (Disease Ontology)
- Hematological tumors
- Exact Synonym (Disease Ontology)
- hematopoietic and lymphoid system tumor
- Exact Synonym (Disease Ontology)
- hematopoietic cancer
- Exact Synonym (Disease Ontology)
- hematopoietic neoplasm
- Exact Synonym (Disease Ontology)
- hematopoietic tumors
- Exact Synonym (Disease Ontology)
- malignant hematopoietic neoplasm